Trial Profile
A phase I study of icotinib hydrochloride exposure in Chinese patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Sep 2015 New trial record
- 01 Sep 2015 Results published in the Cancer.